Nicotine therapeutic benefits: Difference between revisions

Line 1,292:

*The immune phenotype of patients with symptomatic [[wikipedia:Sarcoidosis|'''sarcoidosis''']] treated with nicotine closely resembled that of asymptomatic patients, supporting the notion that nicotine treatment may be beneficial in this patient population.

*[https://www.researchgate.net/profile/Mark_Julian/publication/230645268_Nicotine_Treatment_Improves_TLR2_and_TLR9_Responsiveness_in_Active_Pulmonary_Sarcoidosis/links/556ca4af08aeab77722318be/Nicotine-Treatment-Improves-TLR2-and-TLR9-Responsiveness-in-Active-Pulmonary-Sarcoidosis.pdf PDF Version]

*Citation: Mark W. Julian, MS; Guohong Shao, MD; Larry S. Schlesinger, MD; Qin Huang, MD; David G. Cosmar, BA; Nitin Y. Bhatt, MD; Daniel A. Culver, MD, FCCP; Robert P. Baughman, MD, FCCP; Karen L. Wood, MD, FCCP; and Elliott D. Crouser, MD - ORIGINAL RESEARCH DIFFUSE LUNG DISEASE| VOLUME 143, ISSUE 2, P461-470, FEBRUARY 01, 2013, DOI 10.1378/chest.12-0383

**Citation: Mark W. Julian, MS; Guohong Shao, MD; Larry S. Schlesinger, MD; Qin Huang, MD; David G. Cosmar, BA; Nitin Y. Bhatt, MD; Daniel A. Culver, MD, FCCP; Robert P. Baughman, MD, FCCP; Karen L. Wood, MD, FCCP; and Elliott D. Crouser, MD - ORIGINAL RESEARCH DIFFUSE LUNG DISEASE| VOLUME 143, ISSUE 2, P461-470, FEBRUARY 01, 2013, DOI 10.1378/chest.12-0383

===1988:[https://thorax.bmj.com/content/43/7/516.abstract Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease.]===

*These finding support the possibility that smokers, particularly those with a prominent accumulation of alveolar macrophages in the lower respiratory tract, may be less likely to develop sarcoidosis.

**Citation: Valeyre D, Soler P, Clerici C, et alSmoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease.Thorax 1988;43:516-524.

<br>

@@ Line 1,292: / Line 1,292: @@
 *The immune phenotype of patients with symptomatic [[wikipedia:Sarcoidosis|'''sarcoidosis''']] treated with nicotine closely resembled that of asymptomatic patients, supporting the notion that nicotine treatment may be beneficial in this patient population.
 *[https://www.researchgate.net/profile/Mark_Julian/publication/230645268_Nicotine_Treatment_Improves_TLR2_and_TLR9_Responsiveness_in_Active_Pulmonary_Sarcoidosis/links/556ca4af08aeab77722318be/Nicotine-Treatment-Improves-TLR2-and-TLR9-Responsiveness-in-Active-Pulmonary-Sarcoidosis.pdf PDF Version]
-*Citation: Mark W. Julian, MS; Guohong Shao, MD; Larry S. Schlesinger, MD; Qin Huang, MD; David G. Cosmar, BA; Nitin Y. Bhatt, MD; Daniel A. Culver, MD, FCCP; Robert P. Baughman, MD, FCCP; Karen L. Wood, MD, FCCP; and Elliott D. Crouser, MD - ORIGINAL RESEARCH DIFFUSE LUNG DISEASE| VOLUME 143, ISSUE 2, P461-470, FEBRUARY 01, 2013, DOI 10.1378/chest.12-0383
+**Citation: Mark W. Julian, MS; Guohong Shao, MD; Larry S. Schlesinger, MD; Qin Huang, MD; David G. Cosmar, BA; Nitin Y. Bhatt, MD; Daniel A. Culver, MD, FCCP; Robert P. Baughman, MD, FCCP; Karen L. Wood, MD, FCCP; and Elliott D. Crouser, MD - ORIGINAL RESEARCH DIFFUSE LUNG DISEASE| VOLUME 143, ISSUE 2, P461-470, FEBRUARY 01, 2013, DOI 10.1378/chest.12-0383
-*Acknowledgements: This work was supported by the American Thoracic Society and the Foundation for Sarcoidosis Research. © 2013 American College of Chest Physicians
+***Acknowledgements: This work was supported by the American Thoracic Society and the Foundation for Sarcoidosis Research. © 2013 American College of Chest Physicians
+===1988:[https://thorax.bmj.com/content/43/7/516.abstract Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease.]===
+*These finding support the possibility that smokers, particularly those with a prominent accumulation of alveolar macrophages in the lower respiratory tract, may be less likely to develop sarcoidosis.
+**Citation: Valeyre D, Soler P, Clerici C, et alSmoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease.Thorax 1988;43:516-524.
 <br>